Cargando…
Hyperphosphatemic Tumoral Calcinosis: Pathogenesis, Clinical Presentation, and Challenges in Management
Hyperphosphatemic familial tumoral calcinosis (HFTC) is a rare and disabling disorder of fibroblast growth factor 23 (FGF23) deficiency or resistance. The disorder is manifest by hyperphosphatemia, inappropriately increased tubular reabsorption of phosphate and 1,25-dihydroxy-Vitamin D, and ectopic...
Autores principales: | Boyce, Alison M., Lee, Alisa E., Roszko, Kelly L., Gafni, Rachel I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225339/ https://www.ncbi.nlm.nih.gov/pubmed/32457699 http://dx.doi.org/10.3389/fendo.2020.00293 |
Ejemplares similares
-
Familial Hyperphosphatemic Tumoral Calcinosis
por: Saifuddin, Mohammad, et al.
Publicado: (2023) -
Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use
por: Puar, Akshan, et al.
Publicado: (2022) -
Hyperphosphatemic Familial Tumoral Calcinosis: Odontostomatologic Management and Pathological Features
por: Favia, Gianfranco, et al.
Publicado: (2014) -
Hyperphosphatemic Tumoral Calcinosis: A Classical Clinico-Radio-Scintigraphic Presentation
por: Pal, Rimesh, et al.
Publicado: (2021) -
Hyperphosphatemic Tumoral Calcinosis after Total Knee Arthroplasty
por: Mochizuki, Takeshi, et al.
Publicado: (2017)